Drug Safety Information for DUPIXENT ()

FDA Safety-related Labeling Changes for DUPIXENT (DUPILUMAB) Biological Drug: Safety Information Link

reports of dry eye; Eczema drug Dupixent has updates on clinical trials results. Safety label update for this eczema drug to include a new common side effect of dry eye; pediatric clinical trials info also reported

FDA Adverse Event Summary for DUPIXENT (not avail) Unavailable